XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity (Statement) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Private Placement
Common Stock
Common Stock
Private Placement
Additional paid-in capital
Additional paid-in capital
Private Placement
Accumulated other comprehensive loss
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Private Placement
Beginning balance (in shares) at Dec. 31, 2018       250,283,513              
Beginning balance at Dec. 31, 2018 $ 147,431 $ 107,822   $ 2,502   $ 392,896   $ (29,414) $ (218,553) $ 107,822  
Net income 66,845               66,845    
Other comprehensive (loss) income, net of taxes 5,778             5,778      
Dividends declared (Note 13) (19,023)               (19,023)    
Profit-sharing plan shares, net (in shares)       (258,103)              
Profit‑sharing plan shares, net (1,939)     $ (3)         (1,936)    
Shares issued in connection with deferred compensation plan, net (in shares)       2,233,807              
Shares issued in connection with deferred compensation plan, net (4,972)     $ 22         (4,994)    
Deferred compensation plan voluntary contributions 2,664         2,664          
Payment of shareholder Put and Call rights (in shares)       (632,859)              
Payment of shareholder Put and Call rights (4,952)     $ (6)         (4,946)    
Common Stock Purchase Agreement, net (in shares)         64,509            
Common Stock Purchase Agreement, net     $ 420   $ 1   $ 466       $ (47)
Stock option exercises, net (in shares)       2,979,031              
Stock option exercises, net 784     $ 30   3,009     (2,255)    
Stock-based compensation expense 6,046         6,046          
Shares related to restricted stock, net (in shares)       402,250              
Shares related to restricted stock, net (344)     $ 4   (4)     (344)    
Other (in shares)       5,290              
Other 23         40     (17)    
Ending balance (in shares) at Sep. 30, 2019       255,077,438              
Ending balance at Sep. 30, 2019 306,583     $ 2,550   405,117   (23,636) (77,448)    
Beginning balance (in shares) at Jun. 30, 2019       255,086,392              
Beginning balance at Jun. 30, 2019 288,321     $ 2,550   401,439   (26,998) (88,670)    
Net income 20,427               20,427    
Other comprehensive (loss) income, net of taxes 3,362             3,362      
Dividends declared (Note 13) (6,380)               (6,380)    
Profit-sharing plan shares, net (in shares)       (97,140)              
Profit‑sharing plan shares, net (726)     $ (1)         (725)    
Shares issued in connection with deferred compensation plan, net (in shares)       3,377              
Shares issued in connection with deferred compensation plan, net (19)     $ 0         (19)    
Deferred compensation plan voluntary contributions 788         788          
Payment of shareholder Put and Call rights (in shares)       (231,507)              
Payment of shareholder Put and Call rights (1,803)     $ (2)         (1,801)    
Stock option exercises, net (in shares)       322,004              
Stock option exercises, net 753     $ 3   855     (105)    
Stock-based compensation expense 2,021         2,021          
Shares related to restricted stock, net (in shares)       (7,415)              
Shares related to restricted stock, net (175)     $ 0   0     (175)    
Other (in shares)       1,727              
Other 14         14          
Ending balance (in shares) at Sep. 30, 2019       255,077,438              
Ending balance at Sep. 30, 2019 306,583     $ 2,550   405,117   (23,636) (77,448)    
Beginning balance (in shares) at Dec. 31, 2019       254,842,949              
Beginning balance at Dec. 31, 2019 334,619     $ 2,548   408,667   (23,927) (52,669)    
Net income 74,589               74,589    
Other comprehensive (loss) income, net of taxes (5,284)             (5,284)      
Dividends declared (Note 13) (415,748)               (415,748)    
Profit-sharing plan shares, net (in shares)       (549,834)              
Profit‑sharing plan shares, net (6,970)     $ (5)         (6,965)    
Shares issued in connection with deferred compensation plan, net (in shares)       2,984,531              
Shares issued in connection with deferred compensation plan, net (1,877)     $ 30         (1,907)    
Deferred compensation plan voluntary contributions 2,602         2,602          
Payment of shareholder Put and Call rights (in shares)       (128,176)              
Payment of shareholder Put and Call rights (1,454)     $ (1)         (1,453)    
Common Stock Purchase Agreement, net (in shares)         169            
Common Stock Purchase Agreement, net     $ (57)               $ (57)
Stock option exercises, net (in shares)       3,506,103              
Stock option exercises, net 4,158     $ 35   7,741     (3,618)    
Shares issued for stock grants, net (in shares)       17,411              
Shares issued for stock grants, net 219         219          
Stock-based compensation expense 22,510         22,510          
Shares related to restricted stock, net (in shares)       1,553,883              
Shares related to restricted stock, net (134)     $ 15   (16)     (133)    
Ending balance (in shares) at Sep. 30, 2020       262,227,036              
Ending balance at Sep. 30, 2020 7,173     $ 2,622   441,723   (29,211) (407,961)    
Beginning balance (in shares) at Jun. 30, 2020       259,209,355              
Beginning balance at Jun. 30, 2020 379,744     $ 2,592   415,883   (28,404) (10,327)    
Net income 5,844               5,844    
Other comprehensive (loss) income, net of taxes (807)             (807)      
Dividends declared (Note 13) (400,311)               (400,311)    
Profit-sharing plan shares, net (in shares)       (164,266)              
Profit‑sharing plan shares, net (2,542)     $ (1)         (2,541)    
Shares issued in connection with deferred compensation plan, net (in shares)       24,800              
Shares issued in connection with deferred compensation plan, net (47)               (47)    
Deferred compensation plan voluntary contributions 804         804          
Stock option exercises, net (in shares)       1,321,475              
Stock option exercises, net 4,985     $ 13   5,538     (566)    
Stock-based compensation expense 19,517         19,517          
Shares related to restricted stock, net (in shares)       1,835,672              
Shares related to restricted stock, net (14)     $ 18   (19)     (13)    
Ending balance (in shares) at Sep. 30, 2020       262,227,036              
Ending balance at Sep. 30, 2020 $ 7,173     $ 2,622   $ 441,723   $ (29,211) $ (407,961)